144 related articles for article (PubMed ID: 38384713)
1. A novel serum m
Chen Y; Xie Y; Bi L; Ci H; Li W; Liu D
Front Genet; 2024; 15():1270302. PubMed ID: 38384713
[No Abstract] [Full Text] [Related]
2. m
Zhang B; Chen Z; Tao B; Yi C; Lin Z; Li Y; Shao W; Lin J; Chen J
Mol Cancer; 2021 Dec; 20(1):170. PubMed ID: 34930277
[TBL] [Abstract][Full Text] [Related]
3. Construction of a serum diagnostic signature based on m5C-related miRNAs for cancer detection.
Tang F; Liu Y; Sun Y; Xiong Y; Gu Y; Zhou J; Ouyang Y; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1099703. PubMed ID: 36777349
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatic analysis and
Li W; Kong X; Huang T; Shen L; Wu P; Chen QF
Ann Transl Med; 2020 Nov; 8(21):1422. PubMed ID: 33313167
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
7. A microRNA disease signature associated with lymph node metastasis of lung adenocarcinoma.
Cen SY; Fu KY; Shi Y; Jiang HL; Shou JW; You LK; Han WD; Pan HM; Liu Z
Math Biosci Eng; 2020 Feb; 17(3):2557-2568. PubMed ID: 32233554
[No Abstract] [Full Text] [Related]
8. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
[TBL] [Abstract][Full Text] [Related]
10. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
[TBL] [Abstract][Full Text] [Related]
11. Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study.
Li K; Lin Y; Zhou Y; Xiong X; Wang L; Li J; Zhou F; Guo Y; Chen S; Chen Y; Tang H; Qiu X; Cai S; Zhang D; Bremer E; Jim Yeung SC; Zhang H
Gastroenterology; 2023 Oct; 165(4):932-945.e9. PubMed ID: 37399999
[TBL] [Abstract][Full Text] [Related]
12. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
13. A novel miRNA-based signature as predictive tool of survival outcome of colorectal cancer patients.
Zhao B; Wang W; Ye H; Wang J; Meng K; Yang T
Chem Biol Drug Des; 2023 Nov; 102(5):1024-1033. PubMed ID: 37532274
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
Li W; Liu S; Su S; Chen Y; Sun G
PeerJ; 2021; 9():e10470. PubMed ID: 33510968
[TBL] [Abstract][Full Text] [Related]
15. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
16. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
Chen S; Huang M; Zhang L; Huang Q; Wang Y; Liang Y
Comput Struct Biotechnol J; 2024 Dec; 23():369-383. PubMed ID: 38226313
[TBL] [Abstract][Full Text] [Related]
18. A Novel M7G-Related MicroRNAs Risk Signature Predicts the Prognosis and Tumor Microenvironment of Kidney Renal Clear Cell Carcinoma.
Hong P; Du H; Tong M; Cao Q; Hu D; Ma J; Jin Y; Li Z; Huang W; Tong G
Front Genet; 2022; 13():922358. PubMed ID: 35812727
[No Abstract] [Full Text] [Related]
19. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
20. Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer.
Di Z; Di M; Fu W; Tang Q; Liu Y; Lei P; Gu X; Liu T; Sun M
Front Genet; 2020; 11():192. PubMed ID: 32265979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]